Skip to content
Clinical Trials – home

Azienda Socio Sanitaria Territoriale Ovest Milanese

Verified siteinfo

Italy Via Papa Giovanni Paolo II, 20025 Legnano, Italy

  • 20 trials recruiting
  • Colitis ulcerative · Plasma cell myeloma · Crohn's disease
  • Adults and children

About Specializations

Azienda Socio Sanitaria Territoriale Ovest Milanese in Legnano, Italy specialises in clinical trials of conditions such as Colitis ulcerative, Plasma cell myeloma, Crohn's disease, Non-small cell lung cancer, and other specialisations. This site conducts important research.

Main research areas of the site

Oncology and Hematologic Malignancies

The research portfolio at Azienda Socio Sanitaria Territoriale Ovest Milanese includes a strong focus on neoplasms and blood cancers, especially multiple myeloma, lung cancer, breast cancer, colorectal cancer, urothelial carcinoma, and follicular lymphoma. These studies are designed to evaluate new treatment options, compare them with current standards, and improve outcomes for people with advanced or relapsed disease.

  • Testing new therapies and combinations for relapsed or refractory multiple myeloma
  • Evaluating treatment effectiveness in non-small cell lung cancer and small cell lung cancer
  • Comparing newer approaches for breast cancer, colorectal cancer, and urothelial carcinoma
  • Refining care strategies for follicular lymphoma and other hematologic malignancies

Overall, this site is active in studies that aim to improve survival, disease control, and treatment choice across several major cancer types.

Gastroenterology and Immune-Mediated Disease

Another major area of research covers digestive system diseases and immune system diseases, with trials in ulcerative colitis and Crohn's disease. These studies are focused on understanding how well new therapies work in inflammatory bowel disease and whether they can help patients achieve and maintain remission.

  • Assessing new treatment options for moderately to severely active ulcerative colitis
  • Studying induction and maintenance strategies in Crohn's disease
  • Evaluating whether emerging therapies can improve symptom control and long-term disease management
  • Supporting better care for patients with chronic inflammatory conditions of the bowel

These trials reflect a clear interest in improving both short-term response and ongoing disease control in immune-driven gastrointestinal disorders.

Cardiovascular and Surgical Research

The site also contributes to research in cardiovascular diseases and surgical procedures, including studies related to aortic stenosis, mitral valve surgery, and postoperative low-cardiac output syndrome. This work aims to improve procedural safety, support recovery, and optimize outcomes around major heart interventions.

  • Evaluating supportive approaches during transcatheter aortic valve replacement
  • Studying ways to reduce complications after mitral valve surgery
  • Testing strategies to lower the risk of low-cardiac output syndrome
  • Improving perioperative care in complex cardiovascular procedures

At this hospital and clinic setting, these trials are centered on making advanced cardiac and surgical care safer and more effective.

Kidney, Diagnostic, and Supportive Care Studies

Research at the site also spans hemic and lymphatic diseases, anesthesia and analgesia, and broader health care quality topics, with additional attention to non-diabetic chronic kidney disease and diagnostic refinement in cancer care. These studies explore whether new approaches can slow kidney disease progression, improve treatment selection, and support better patient management.

  • Testing therapies aimed at slowing progression in non-diabetic chronic kidney disease
  • Exploring diagnostic tools and biomarkers to guide cancer treatment decisions
  • Assessing supportive and perioperative care approaches that may improve patient comfort and safety
  • Strengthening the quality and effectiveness of care delivered in a general surgery environment

This broad research activity shows the site’s interest in both treatment innovation and practical improvements in everyday clinical care.

Complex Abdominal Wall and Hernia Repair

Within general surgery, the site is involved in studies on complex hernia repair and abdominal wall reconstruction. The focus is on patients with challenging hernia anatomy, where researchers are evaluating methods that may improve surgical planning, tissue mobility, and overall repair outcomes.

  • Studying new approaches for large and complex abdominal hernias
  • Evaluating ways to improve abdominal wall reconstruction
  • Assessing whether pre-surgical interventions can support better operative results
  • Advancing practical techniques for difficult surgical cases

These trials highlight the site’s role in developing more effective solutions for patients with technically demanding surgical problems.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Via Papa Giovanni Paolo II20025 LegnanoItaly
Recruiting now
20 trials
Conditions studied
21
Partner status
Verified site

More sites in LegnanoItaly

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

36 clinical trials

Phase 2 Study of Nemolizumab for Skin Thickening in Adults with Systemic Sclerosis

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Nemolizumab
  • Sponsor:Galderma S.A.

Long‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:SPY002
  • Sponsor:Spyre Therapeutics Inc.

Crohn's disease

Recruiting

A study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease

Investigational
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Duvakitug
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Crohn's disease

Recruiting

A study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease

Investigational
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Duvakitug
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Phase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:AstraZeneca AB

A Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:SPY002
  • Sponsor:Spyre Therapeutics Inc.

A study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy

Investigational
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Duvakitug
  • Sponsor:Sanofi-Aventis Recherche & Developpement

A study testing duvakitug for patients with moderately to severely active ulcerative colitis

Investigational
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Duvakitug
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Phase 2 Randomized Double‑Blind Placebo‑Controlled Study of MH002 in Adults with Mild‑to‑Moderate Ulcerative Colitis Inadequately Controlled by 5‑ASA

Investigational
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years · 65+ years

Hernia repair

Recruiting

A Study of Botulinum Toxin Type A for Preparing the Abdominal Wall Before Surgery in Patients with Large Complex Hernias

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Botulinum Toxin Type A - Haemagglutinin Complex
  • Sponsor:Azienda Socio Sanitaria Territoriale Ovest Milanese

Study comparing daratumumab, lenalidomide and dexamethasone followed by linvoseltamab versus continued initial treatment in newly diagnosed multiple myeloma patients

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Daratumumab
  • Sponsor:Emn Trial Office S.r.l. Impresa Sociale

Study of datopotamab deruxtecan with platinum-based therapy compared to gemcitabine with platinum-based therapy in patients with advanced urothelial cancer after prior treatment

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Daiichi Sankyo Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.